Hydroxychloroquine tablets bulk supplier for pharma manufacturers

Hydroxychloroquine Tablets 200 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200 mg

Reference Brands: Plaquenil(US & EU)

Category: Arthritis

Hydroxychloroquine sulfate 200 mg film-coated tablets, a disease-modifying drug for rheumatoid arthritis and lupus. For importers, distributors, hospital and rheumatology pharmacies and tender buyers.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Hydroxychloroquine Tablets? List it or send an offer →

Product Description:

Hydroxychloroquine is a 4-aminoquinoline, first developed as an antimalarial and now used mainly as a disease-modifying drug in rheumatology. It concentrates in lysosomes and raises their pH, interfering with antigen processing and toll-like receptor signalling. This page covers the 200 mg film-coated tablet of hydroxychloroquine sulfate, about 155 mg base, used in almost all adult regimens. The coat masks the bitter taste.

Main uses are rheumatoid arthritis, systemic lupus erythematosus and discoid lupus; in lupus it is often long-term background therapy. Some labels still include malaria, though resistance limits that use. Tablets are taken with food or milk, and antacids are separated by at least four hours. The key long-term risk is retinal toxicity, so guidance keeps the daily dose at no more than 5 mg per kg of actual body weight, with regular eye screening. Labels also warn about QT prolongation, hypoglycaemia and dangerous overdose in children.

Sourcing notes. Hydroxychloroquine is prescription-only and registered on a bioequivalence dossier in CTD or ACTD format. Confirm the label strength is expressed as the sulfate, which is standard. Tablets come in PVC/aluminium or alu-alu blisters or HDPE bottles; child-resistant packs are worth considering given overdose toxicity. Store at room temperature, protected from light and moisture, with no cold chain. Ask for Zone IVb stability data, a batch certificate of analysis with dissolution and impurities, the GMP certificate and a CoPP. Some authorities monitor demand closely, so check current national controls. Give pack type, quantity, labelling language and any tender reference.

Hydroxychloroquine Tablets — third party manufacturing & bulk supply

Hydroxychloroquine Tablets 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Hydroxychloroquine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Hydroxychloroquine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Hydroxychloroquine Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Hydroxychloroquine tablets is listed as Tablets in 200 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Hydroxychloroquine tablets is referenced against Plaquenil(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.